Skip to main content
Premium Trial:

Request an Annual Quote

InforMax Licenses GenoMax to Abgenix

NEW YORK, May 10 -  InforMax has licensed its GenoMax bioinformatics software to Abgenix, the company said Thursday.

The licensing agreement, which occurred during the first quarter, comprises one of 32 sales to pharmaceutical, biotechnology, and academic customers, according to InforMax CEO Alex Titomirov.

GenoMax integrates UNIX, Oracle, and Java technologies for analysis of mass quantities of genomic data and target selection. It works in tandem with Vector NTI suite, InforMax's desktop product for wet lab work.

"The GenoMax bioinformatics system will help us to organize and manage the genomics data for our antibody-based therapeutics,” said Keith Joho, director of bioinformatics for Abgenix, in a statement. “We expect GenoMax to help expedite our analysis of targets and antibodies in our large-scale product discovery efforts." 

The companies did not disclose the financial details of the agreement. 

Other InforMax customers for GenoMax include the Whitehead Institute/MIT Center for Genome Research, PPD Discovery, DuPont, Pioneer Hi-Bred International, Genzyme, The University of Tokyo, and AxCell Biosciences, in collaboration with which the company has added a database of human protein interactions to the product. InforMax, of Rockville, Md., claims to have over 22,000 individual users of its software worldwide at 1,300 research organizations. 

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.